UCB (UCBJF) announced it will present pioneering TK2d research at the UMDF Mitochondrial Medicine 2025 Conference taking place June 18-21, 2025, in St. Louis, Missouri. UCB will present findings from disease course studies of TK2d in untreated patients, looking at disease progression and outcomes over time, as well as real-world insights into the burden and impact on caregivers, providing a comprehensive view of the experiences and challenges faced by those supporting individuals with TK2d.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UCBJF: